Sykes And Ray Equities Open An Account Button
SRE India Mobile Trading App Download Promotion
Sykes And Ray Equities India Start SIP Investment Visual
Sykes And Ray Equities India Start Trading Online Visual

Markets

Market Nav

INCOME STATEMENT

You can view the income statement for the last 5 years.
Welcure Drugs & Pharmaceuticals Ltd.
( in Crs.)

ParticularsMar 26Mar 25Mar 24Mar 23Mar 22
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)ARARARARAR
FaceValue1.0010.0010.0010.0010.00
      
      
INCOME     
Revenue From Operations [Net]24.550.000.000.000.00
Other Operating Revenues0.000.000.000.110.13
Total Operating Revenues24.550.000.000.110.13
      
Other Income1.910.090.240.000.00
Total Revenue26.460.090.240.110.13
      
EXPENSES     
Purchase Of Stock-In Trade164.030.000.000.000.00
Changes In Inventories Of FG,WIP And Stock-In Trade-143.520.000.000.000.00
Employee Benefit Expenses0.280.090.040.010.01
Depreciation And Amortisation Expenses0.010.040.000.000.00
Other Expenses2.890.150.090.070.07
Total Expenses23.680.270.140.080.08
      
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax2.78-0.170.100.020.06
      
Profit/Loss Before Tax2.78-0.170.100.020.06
      
Tax Expenses-Continued Operations     
Deferred Tax0.610.000.000.000.00
Total Tax Expenses0.610.000.000.000.00
Profit/Loss After Tax And Before ExtraOrdinary Items2.17-0.170.100.020.06
      
Profit/Loss From Continuing Operations2.17-0.170.100.020.06
      
Profit/Loss For The Period2.17-0.170.100.020.06
      
OTHER INFORMATION     
      
EARNINGS PER SHARE     
Basic EPS (Rs.)0.36-0.120.080.020.05
Diluted EPS (Rs.)0.36-0.120.080.020.05